Work

Toxicities and Outcome after CD19-directed Chimeric Antigen Receptor T-cell Therapy for Neurolymphomatosis (S29.010)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211257

Authors: Jorg Dietrich, Philipp Karschnia, Sofia Doubrovinskaia, Wolfgang Wick, Maria Martinez-Lage, Ganesh Shankar, Jeremy Abramson, Matthew Frigault, Leon Kaulen

Institutions: Neurology, Inc, Friedrich-Alexander-Universität Erlangen-Nürnberg, Heidelberg University, Harvard University, Massachusetts General Hospital

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409237244

FWCI:

Cites:

Cited by:

Related to: 10